Action receives patent for RPE cells to treat retinal degeneration Advanced Cell Technology.

We’ve worked hard to build up an efficient way for making a renewable way to obtain transplantable RPE cells that can be used to target illnesses such as Stargardt’s Disease and Age-related Macular Degeneration. For most of these patients there are no obtainable treatments. We’ve demonstrated that our stem cell-derived RPE cells can rescue visual function in pets that otherwise could have gone blind. We are looking forward to starting our scientific trials with the hope these cells will become similarly efficacious in patients.’ Related StoriesPublic policy had a need to decrease stem cell tourism, say expertsKey protein controls stem cell properties that will make them useful in regenerative medicineUS and German researchers team up to advance quality control of human being stem cells’We think that these patents are specially important as they extend the company’s patent coverage of the scalable manufacturing of human RPE cells for therapeutic use, which are core to our item and technology portfolio,’ continuing Mr.We want to provide these physicians the tools they need to interpret screening mammograms at the highest level. Carney acknowledges the total results of the study are controversial. This is the first time anyone has identified criteria for low efficiency, she says, but women having mammograms shouldn’t be overly worried by these results because every mammography facility has a designated physician who’s charged with monitoring obtainable performance steps. Carney advises all women to talk to their physicians about their issues relating to screening mammograms and their personal risk factors for breast cancer. If you have any issues at all, based upon your risk, you could ask for a second interpreter to check out your film.